Viromed Laboratories, Inc.
United StatesFDA applicant, unverified
- Devices
- 25
What Viromed Laboratories, Inc. makes
Viromed Laboratories, Inc. produces cell cultures and cell culture media used in virology testing and vaccine development, including human-derived cell lines (e.g., HeLa, HEP-2) and animal-derived cell lines (e.g., monkey kidney, rabbit kidney, MDCK, BHK-21). Their portfolio also includes specialized media like SF Refeeding Media for maintaining cell viability and supporting viral propagation.
These products are classified as Class I medical devices under FDA regulations and are listed in the FDA’s 510(k) registry. The company operates from the United States, adhering to applicable U.S. regulatory requirements for cell culture products.
Catalogue
Search and filter all 25 devicesFrequently asked questions
How many devices does Viromed Laboratories, Inc. have in the registry?
The registry currently lists 25 devices for Viromed Laboratories, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Viromed Laboratories, Inc.'s devices?
Among its 25 most recently registered devices, Viromed Laboratories, Inc. has devices listed in FDA 510(k) (25 devices).
What risk classes do Viromed Laboratories, Inc.'s devices fall under?
Among its 25 most recently registered devices, the classes recorded for Viromed Laboratories, Inc.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Viromed Laboratories, Inc. in the registry?
The most recently registered devices listed for Viromed Laboratories, Inc. include HEK, LLC-MK2 (MONKEY KIDNEY, MACACA MULATA) CELL CULTURE, HUMAN EPITHELOID CERVIX CARCINOMA CELLS (HELA) and RABBIT KIDNEY CELLS.